CLINICAL FEATURES OF THE COURSE OF COVID-19, GASTROENTEROLOGICAL MANIFESTATIONS OF THE DISEASE
Abstract
The gastrointestinal tract is one of the most susceptible systems of the body to the SARS-CoV-2 virus. Typical gastroenterological complaints of patients, clinical and laboratory changes from the intestines, hepatopancreatobiliary system, increased activity of liver and pancreatic enzymes, especially in patients with a severe course of the disease are confirmation of changes on the part of the digestive system against the background of the debut and the expanded picture of COVID-19.Purpose: to present in the form of a lecture the results of an analytical review of the data of domestic and foreign literature devoted to the study of the features of the clinical and laboratory-instrumental course of COVID-19.Material and methods. A systematic analysis of domestic and foreign literature data based on our own experience in the examination and treatment of patients with COVID-19.Results and conclusions. The course of COVID-19 is characterized not only by signs of respiratory damage, but also by fairly pronounced symptoms from the gastrointestinal tract. The scientific substantiations of the need for new approaches are presented not only to the early comprehensive diagnosis, stratification of the risks of severe disease and its complications, but also to the treatment of COVID-19, prevention of its complications and Post-COVID-19 syndrome.
About the Authors
V. B. Grinevich
ФГБВОУ ВО «Военно-медицинская академия имени С.М. Кирова» МО РФ
Russian Federation
Russian Federation
A. K. Ratnikova
ФГБВОУ ВО «Военно-медицинская академия имени С.М. Кирова» МО РФ; ФГБУ «Северо-западный окружной научно-клинический центр им. Л.Г. Соколова» ФМБА России
Russian Federation
Russian Federation
V. A. Kashchenko
ФГБУ «Северо-западный окружной научно-клинический центр им. Л.Г. Соколова» ФМБА России; ФГБОУ ВО «Санкт-Петербургский государственный университет»
Russian Federation
Russian Federation
V. A. Ratnikov
ФГБУ «Северо-западный окружной научно-клинический центр им. Л.Г. Соколова» ФМБА России; ФГБОУ ВО «Санкт-Петербургский государственный университет»
Russian Federation
Russian Federation
References
1. Day, M. Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village / M. Day // BMJ. - 2020. - Vol. 368. - P. m1165.
2. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19) / H. Nishiura [et al.] // Int. J. Infect. Dis. - 2020. - Vol. 94, № 1. - P. 154-155.
3. Thuluvath, P.J. What GI physicians need to know during COVID-19 pandemic / P.J. Thuluvath [et al.] // Dig. Dis. Sci. - 2021. - Vol. 66, № 7. - P. 2865-2875.
4. Epidemiology of COVID-19 among children in China / Y. Dong [et al.] // Pediatrics. - 2020. - Vol. 145, № 6. - P. e20200702.
5. Coronavirus Disease 2019 in Children /S. Bialek [et al.] // MMWR Morb. Mortal. Wkly Rep. - 2020. - Vol. 69, № 14. - P. 422-426.
6. Parri, N. Children with Covid-19 in pediatric emergency departments in Italy / N. Parri, M. Lenge, D. Buonsenso // N. Engl. J. Med. - 2020. - Vol. 383, № 2. - P. 187-190.
7. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China / C. Huang [et al.] // Lancet. - 2020. - Vol. 395, № 10223. - P.497-506.
8. Gender differences in patients with Covid-19: focus on severity and mortality / J.-M. Jin [et al.] // Front. Public Health. - 2020. - Vol. 8, № 1. - P. 152.
9. Особенности тромбоэластографического профиля пациентов с COVID-19 в условиях ОРИТ / А.В. Самородов [и др.] // Вестник анестезиологии и реаниматологии. - 2020. - Т. 17, № 6. - С. 39-44.
10. Prevalence of obesity among adult in patients with Covid-19 in France / C. Caussy [et al.] // Lancet Diabetes Endo. - 2020. - Vol. 8, № 7. - P. 562-564.
11. Clinical course and risk factors for mortality of adult in patients with Covid-19 in Wuhan, China: a retrospective cohort study / F. Zhou [et al.] // Lancet. - 2020. - Vol. 395, № 10229. - P. 1054-1062.
12. CT features of Coronavirus Disease 2019 (Covid-19) pneumonia in 62 patients in Wuhan, China / S. Zhou [et al.] // Am. J. Roentgenol. - 2020. - Vol. 214, № 6. - P. 1287-1294.
13. Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия-13 (14.10.2021). - М., 2021. - 224 с.
14. Time course of lung changes at chest CT during recovery from Coronavirus Disease 2019 (Covid-19) / F. Pan [et al.] // Radiology. - 2020. - Vol. 295, № 3. - P. 715-721.
15. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wu-han, China / C. Wu [et al.] // JAMA Intern. Med. - 2020. - Vol. 180, № 7. - P. 1-11.
16. Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East Respiratory Syndrome coronavirus infection in the United Arab Emirates, April 2014 / Dl. Ng [et al.] // Am. J. Pathol. - 2016. - Vol. 186, № 3. - P. 652-658.
17. Pathological findings of Covid-19 associated with acute respiratory distress syndrome / Z. Xu [et al.] // Lancet Resp. Med. - 2020. - Vol. 8, № 4. - P. 420-422.
18. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study / J.R. Lechien [et al.] // Eur. Arch. Otorhinolaryngol. - 2020. - Vol. 277, № 10. - P. 2251-2261.
19. Luo, S. Don’t overlook digestive symptoms in patients with 2019 novel coronavirus disease (COVID-19) / S. Luo, X. Zhang, H. Xu // Clin. Gastroenterol. Hepatol. - 2020. - Vol. 18, № 8. - P. 1636-1637.
20. Clinical characteristics of coronavirus disease 2019 in China / G.Wei-jie [et al.] // N. Engl. J. Med. - 2020. - Vol. 382, № 8. - P. 1708-1720.
21. Epidemiological and clinical characteristics of 99 cases of 2019 Novel Coronavirus pneumonia in Wuhan, China: A descriptive Study / N. Chen [et al.] // Lancet. - 2020. - Vol. 395, № 10223. - P. 507-513.
22. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China / C. Huang [et al.] // Lancet. - 2020. - Vol. 395, № 10223. - P. 497-506.
23. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study / L. Pan [et al.] // Am. J. Gastroenterol. - 2020. - Vol. 115, № 6. - P. 766-773.
24. Digestive symptoms in COVID-19 patients with mild disease severity: clinical presentation, stool viral RNA testing, and outcomes / C. Han [et al.] // Am. J. Gastroenterol. - 2020. - Vol. 115, № 6. - P. 916-923.
25. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from the Hong Kong cohort and systematic review and metaanalysis. K.S. Cheung [et al.] // Gastroenterology. - 2020. - Vol. 159, № 1. - P. 81-95.
26. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China / D. Wang [et al.] // JAMA. - 2020. - Vol. 323, № 6. - P. 1061-1069.
27. Prevalence of gastrointestinal symptoms and fecal viral shedding in patients with Coronavirus Disease 2019 / S. Parasa [et al.] // JAMA Netw. Open. - 2020. - Vol. 3, № 6. - P. E2011335.
28. High prevalence of concurrent gastrointestinal manifestations in patients with SARSCoV-2: early experience from California / G. Cholankeril [et al.] // Gastroenterology. - 2020. - Vol. 159, № 2. - P. 775-777.
29. Are gastrointestinal symptoms specific for COVID-19 infection? A prospective case-control study from the United States / A. Chen [et al.] // Gastroenterology. - 2020. - Vol. 159, № 3. - P. 1161-1163e2.
30. Gastrointestinal symptoms and coronavirus disease 2019: a case-control study from the United States / Y.R. Nobel [et al.] // Gastroen-terology. - 2020. - Vol. 159, № 1. - P. 373-375e2.
31. Clinical characteristics of COVID-19 in New York City / P. Goyal [et al.] // N Engl J Med. - 2020. - Vol. 382, № 24. - P. 2372-2374.
32. Three cases of COVID-19 disease with colonic manifestations / Y. Sattar [et al.] // Am. J. Gastroenterol. - 2020. - Vol. 115, № 6. - P. 948-950.
33. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study / H. Shi [et al.] // Lancet Infect. Dis. - 2020. - Vol. 20, № 2. - P. 425-434.
34. Elevated liver biochemistries in hospitalized Chinese patients with severe COVID-19: systematic review and meta-analysis / A. Kovalic [et al.] // Hepatology. - 2021. - Vol. 73, № 4. - P. 1521-1530.
35. Kunutsor, S.K. Markers of liver injury and clinical outcomes in COVID-19 patients: a systematic review and metaanalysis / S.K. Kunut-sor, J.A. Laukkanen // J. Infect. - 2021. - Vol. 82, № 1. - P. 159-198.
36. Remdesivir for the treatment of COVID-19-preliminary report / J.H. Beigel [et al.] // N. Engl. J. Med. - 2020. - Vol. 383, № 19. - P. 1813-1826.
37. Remdesivir for 5 or 10 days in patients with severe COVID-19 / J.D. Goldman [et al.] // N. Engl. J. Med. - 2020. - Vol. 383, № 19. - P. 1827-1837.
38. COVID-19: abnormal liver function tests / Q. Cai [et al.] // J. Hepatol. - 2020. - Vol. 73, № 3. - P. 566-574.
39. COVID-19 and liver / D. Jothimani [et al.] // J. Hepatol. - 2020. - Vol. 73, № 5. - P. 1231-1240.
40. Baseline characteristics and outcomes of 1591 patients infected with SARSCoV-2 admitted to ICUs of the Lombardy Region, Italy / G. Grasselli [et al.] // JAMA. - 2020. - Vol. 323, № 6. - P. 1574-1581.
41. Mantovani, A. Coronavirus disease 2019 and prevalence of chronic liver disease: a meta-analysis / A. Mantovani, G. Beatrice, A. Dal-beni // Liver Int. - 2020. - Vol. 40, № 7. - P. 1316-1320.
42. Kovalic, A.J. Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis / A.J. Kovalic, S.K. Satapathy, P.J. Thuluvath // Hepatol. Int. - 2020. - Vol. 14, № 5. - P. 612-620.
43. Гемодинамические и метаболические нарушения в условиях HIPEC лечения интраперитонеально диссеминированного рака яичников / М.В. Забелин [и др.] // Здравоохранение, образование и безопасность. - 2020. - № 4 (24). - С. 7-17.
44. Pre-existing liver disease is associated with poor outcomes with SARS CoV2 infection: the APCOLIS study (APASL COVID-19 liver injury spectrum study) / Sarin S.K. [et al.] // Hepatology Int. - 2020. - Vol. 4, № 1. - P.1-11.
45. Pathological findings of COVID-19 associated with acute respiratory distress syndrome / Z. Xu [et al.] // Lancet Respir. Med. - 2020. - Vol. 8, № 2. - P. 420-422.
46. Liver and COVID-19 infection: a very preliminary lesson learnt from histological post-mortem findings in 48 patients. 2020 [Electronic resource] / A. Sonzogni [et al.] // Preprints. - 2020. URL: https://www.preprints.org/manuscript/202004.0438/v1 (accessed 17.09.2021).
47. Postmortem examination of patients with COVID-19 / T. Schaller [et al.] // JAMA. - 2020. - Vol. 323, № 24. - P. 2518-2520.
48. Hajifathalian, K. Gastrointestinal and hepatic manifestations of 2019 novel Coronavirus disease in a large cohort of infected patients from New York: clinical implications for prognosis / K. Hajifathalian, T. Krisko, A. Mehta // Gastroenterology. - 2020. - Vol. 159, № 3. - P. 1137-1140e2.
49. An updated meta-analysis of AST and ALT levels and the mortality of COVID-19 patients / Y. Wang [et al.] // Am. J. Emerg. Med. - 2020. - Vol. 40. - P. 208-209.
50. The association of low serum albumin level with severe COVID-19: a systematic review and meta-analysis / M. Aziz [et al.] // Crit. Care. - 2020. - Vol. 24. - P. 255.
51. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study / X. Yang [et al.] // Lancet Respir. Med. - 2020. - Vol. 8, № 5. - P. 475-481.
52. Factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients. Open-SAFELY / E. Williamson [et al.] // Nature. - 2020. - Vol. 584, № 2. - P. 430-436.
53. High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: preliminary results from an international registry / A.M. Moon [et al.] // J. Hepatol. - 2020. - Vol. 73, № 3. - P. 705-708.
54. Singh, S. Clinical characteristics and outcomes of COVID-19 among patients with pre-existing liver disease in United States: A multi-center research network study / S. Singh, A. Khan // Gastroenterology. - 2020. - Vol. 159, № 2. - P. 768-771.e3.
55. Особенности ведения коморбидных пациентов в период пандемии новой коронавирусной инфекции (COVID-19). Национальный консенсус 2020 / В.Б. Гриневич [и др.] // Кардиоваскулярная терапия и профилактика. - 2020. - Т. 19, № 4. - С. 2630.
56. New-onset diabetes in Covid-19 / F. Rubino [et al.] // N. Engl. J. Med. - 2020. - Vol. 383, № 4. - P. 789-790.
57. Clinical characteristics and outcomes of Covid-19 hospitalized patients with diabetes in the United Kingdom: a retrospective single centre study / A. Alkundi [et al.] // Diabetes Res. Clin. - 2020. - Vol. 165. - P. 108263.
58. Coronavirus Disease-19 (COVID-19) associated with severe acute pancreatitis: case report on three family members / A. Hadi [et al.] // Pancreatology. - 2020. - Vol. 20, № 4. - P. 665-667.
59. COVID-19 presenting as acute pancreatitis / M.M. Aloysius [et al.] // Pancreatology. - 2020. - Vol. 20, № 5. - P. 1026-1027.
60. Pancreatic injury patterns in patients with COVID-19 pneumonia / F. Wang [et al.] // Gastroenterology. - 2020. - Vol. 159. - P. 367-370.
61. Asti, E. Gangrenous cholecystitis during hospitalization for SARS-CoV2 infection / E. Asti, A. Lovece, L. Bonavina // Updates Surg. - 2020. - Vol. 72, № 3. - P. 917-919.
62. Novel coronavirus disease 2019 in a patient on durable left ventricular assist device support / R. Singh [et al.] // J. Card. Fail. - 2020. - Vol. 26. - P. 438-439.
63. AGA clinical practice update on management of inflammatory bowel disease during the COVID-19 pandemic: expert commentary / D.T. Rubin [et al.] // Gastroenterology. - 2020. - Vol. 159, № 1. - P. 350-357.
64. Mahase, E. COVID-19: low dose steroid cuts death in ventilated patients by one third, trial finds / E. Mahase // BMJ. - 2020. - Vol. 369. - P. m2422.
65. Coronavirus (COVID-19) outbreak: what the department of endoscopy should know / A. Repici [et al.] // Gastrointest. Endosc. - 2020. - Vol. 92, № 1. - P. 192-197.
66. Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper / T. Boettler [et al.] // J. HEP. Rep. - Vol. 2. - P. 100113.
67. Remuzzi, A. COVID-19 and Italy: What next? / A. Remuzzi, G. Remuzzi // Lancet. - 2020. - Vol. 395, № 10223. - P. 1225-1228.
68. Ведение пациентов с заболеваниями органов пищеварения в период пандемии COVID-19: клинические рекомендации Российского научного медицинского общества терапевтов и Научного общества гастроэнтерологов России (2-е изд.) / В.Б. Гриневич [и др.] // Экспериментальная и клиническая гастроэнтерология. - 2021. - №. 3. - C. 5-82.
69. Chloroquine for COVID-19: rationale, facts, hopes / A. Cortegiani [et al.] // Critic. Care. - 2020. - Vol. 24, № 1. - P. 210.
70. Observational study of hydroxychloroquine in hospitalized patients with Covid-19 / J. Geleris [et al.] // N. Engl. J. Med. - 2020. - Vol. 382, № 25. - P. 2411-2418.
71. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial / Y. Wang [et al.] // Lancet. - 2020. - Vol. 395, № 10236. - P. 1569-1578.
72. Compassionate use of remdesivir for patients with severe Covid-19 / J. Grein [et al.] // N. Engl. J. Med. - 2020. - Vol. 382, № 24. - P. 2327-2336.
73. Забелин, М.В. Эффективность оздоровительно-рекреационной программы у работников медицинского учреждения / М.В. Забелин, А.С. Сафонов // Здравоохранение, образование и безопасность. - 2019. - № 3(19). - С. 17-26.
Review
For citations:
Grinevich V.B., Ratnikova A.K., Kashchenko V.A., Ratnikov V.A. CLINICAL FEATURES OF THE COURSE OF COVID-19, GASTROENTEROLOGICAL MANIFESTATIONS OF THE DISEASE. Bashkortostan Medical Journal. 2021;16(5):76-86. (In Russ.)
Views:
95
Email this article 
